INSIGHTS ON CLINICAL TRIAL PARTNERING

• Early Oncology Clinical Trials: Key Considerations To Plan For Success

  This presentation outlines the key success factors driving high-impact oncology drug development, with a focus on translating innovative science into clinically and commercially meaningful outcomes.

• Innovation Under Pressure: Navigating Clinical Trials Amid a Pandemic

  How do you complete a Phase 2b rheumatology study in three countries despite global lockdowns? Palleos cracked the code, achieving recruitment targets and regulatory approvals against all odds.

• Streamlining Patient Recruitment With AI–Driven Site Identification

  This study highlights the use of an RWD-driven, AI-enabled recruitment models as a transformative strategy for clinical development in hard-to-recruit populations.

• Advancing Oncology Innovation With Adaptive Trial Designs

  When a biopharmaceutical company developing a novel therapy for solid tumor cancers became concerned with rapid over-enrollment from within a single region, they employed a CRO for assistance.

• Rethinking Clinical Operations: A Smarter, Faster Playbook For Trial Success

  10/15/2025

  The CRO-sponsor partnership is now strategic, addressing communication gaps and fragmented systems to improve efficiency. Joint governance, real-time tracking, and unified technology accelerate complex trial execution.

• Working With A Specialty Oncology CRO Versus A Large Generalist CRO

  10/2/2025

  Specialty oncology CROs bridge the gap between traditional CRO operating models and the specialized needs of oncology sponsors by embedding deep oncology expertise across every function.

• How Strategic LQPPV Outsourcing Future-Proofs PV Compliance In The AI Era

  8/8/2025

  As health authorities seek standardization across global processes and strong AI governance, working with an experienced PV partner will help minimize the burden of oversight and ensure compliance.

• Decisions In Cell And Gene Therapy Development

  7/2/2024

  Explore critical decisions across clinical trial design, patient recruitment, site selection, logistics, manufacturing, and long-term follow-up, aiming to guide stakeholders through CAGT development.

• Building Bioanalysis Infrastructure For Modern Drug Development

  10/20/2025

  Drug development accelerates with AI, decentralized trials, and adaptive protocols, but legacy CRO infrastructure lags. Platform-based systems enable speed, quality, automation, and continuous improvement.